z-logo
open-access-imgOpen Access
LncRNA PCAT-1 in gastrointestinal cancers
Author(s) -
Wanwei Liu,
Jiwei Xu
Publication year - 2018
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000013429
Subject(s) - medicine , hazard ratio , meta analysis , oncology , cochrane library , odds ratio , confidence interval , prostate cancer , subgroup analysis , cancer , proportional hazards model , metastasis
High expression of PCAT-1 was related to poor prognosis and could be a promising biomarker of clinicopathologic features in gastrointestinal cancers. More studies will be necessary to verify and strengthen the clinical value of PCAT-1 in gastrointestinal cancers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom